Faber J, Kirkegaard C, Rasmussen B, Westh H, Busch-Sørensen M, Jensen I W
J Clin Endocrinol Metab. 1987 Aug;65(2):315-20. doi: 10.1210/jcem-65-2-315.
Severe nonthyroidal illness has been claimed to cause secondary hypothyroidism. We reevaluated this concept measuring serum free T4 and free T3 by an ultrafiltration method and serum TSH by an ultrasensitive technique (detection limit, and serum TSH by an ultrasensitive technique (detection limit, 0.05 mU/L). Forty-five critically ill patients suffering from hepatic coma (n = 10), terminal cancer (n = 9), stroke (n = 8), and respiratory insufficiency not treated (n = 7) and treated (n = 11) with dopamine were studied. The mortality rate was 80%. No patients received glucocorticoids, and only patients in the last group received dopamine. Serum total as well as free thyroid hormone index values were grossly reduced in the majority of the patients. The 34 patients not receiving dopamine in general had normal values of serum free T4 (32 of 34) and free T3 (31 of 34), measurable TSH (33 of 34), and detectable TSH responses to iv TRH (33 of 34). In contrast, the dopamine-treated patients had reduced serum free T4 and TSH levels compared to normal subjects (P less than 0.05), as well as reduced TSH responses to TRH (P less than 0.01). Serum free T4 and free T3 were below the normal range in 3 patients and 1 patient, respectively, and serum TSH was below the detection limit in 2 patients. We conclude that critically ill patients with nonthyroidal illness not receiving dopamine have normal pituitary-thyroid function, whereas dopamine induces some degree of secondary hypothyroidism.
严重的非甲状腺疾病被认为可导致继发性甲状腺功能减退。我们通过超滤法测定血清游离T4和游离T3,并采用超敏技术(检测限为0.05 mU/L)测定血清促甲状腺激素(TSH),对这一概念进行了重新评估。研究了45例重症患者,包括肝昏迷患者(n = 10)、晚期癌症患者(n = 9)、中风患者(n = 8)以及未接受治疗(n = 7)和接受多巴胺治疗(n = 11)的呼吸功能不全患者。死亡率为80%。没有患者接受糖皮质激素治疗,只有最后一组患者接受了多巴胺治疗。大多数患者的血清总甲状腺激素以及游离甲状腺激素指数值大幅降低。一般来说,34例未接受多巴胺治疗的患者血清游离T4(34例中的32例)、游离T3(34例中的31例)、可测量的TSH(34例中的33例)以及对静脉注射促甲状腺激素释放激素(TRH)的可检测TSH反应(34例中的33例)均正常。相比之下,与正常受试者相比,接受多巴胺治疗的患者血清游离T4和TSH水平降低(P < 0.05),对TRH的TSH反应也降低(P < 0.01)。血清游离T4和游离T3分别在3例和1例患者中低于正常范围,血清TSH在2例患者中低于检测限。我们得出结论,未接受多巴胺治疗的非甲状腺疾病重症患者垂体 - 甲状腺功能正常,而多巴胺会诱发一定程度的继发性甲状腺功能减退。